In contrast to general patterns of racial differences in health care utilization,[@CR1],[@CR2] including lower rates of invasive cardiac procedures,[@CR3]--[@CR11] surgical treatment for lung cancer[@CR12] and renal transplantation[@CR13],[@CR14] among blacks, at the end of life, blacks appear to receive higher rates of intensive treatment. For example, blacks are more likely to die in the hospital[@CR15] and less likely to use hospice[@CR16] and have higher overall spending in their last 12 months than whites.[@CR17]--[@CR19] Some have tried to explain these phenomena by citing differences in patient preferences. Indeed, several studies report that blacks and Hispanics prefer more aggressive life-sustaining treatment than whites,[@CR20]--[@CR23] and that physicians' preferences for end-of-life treatment follow the same pattern by race as patients' preferences.[@CR24] However, treatment preferences for care at the end of life do not reliably predict actual treatment.[@CR15],[@CR25]

Recent studies have explored the role of region,[@CR26] hospital,[@CR27]--[@CR29] and individual provider[@CR30] in observed racial differences in health care utilization. With respect to end-of-life care, an analysis of Medicare claims found that aggregate ICU admissions and hospital days in the last 6 months of life are driven more by region of residence than by race[@CR31] and an analysis of terminal hospital discharges from 6 states found that the majority of observed differences in ICU use among black and Hispanic decedents were attributable to their use of hospitals with higher ICU use rather than to racial differences in ICU use within the same hospital.[@CR32]

Secular increases in ICU admission and intensive inpatient procedure use have occurred among both decedents and survivors[@CR33]; little is known about the respective trends by race. Building upon our previous work, we sought to describe the effect of race on inpatient ICU and intensive procedure use among Medicare decedents over 10 years, adjusting for hospital-level effects in the analyses and using utilization among survivors for comparison. We hypothesized that hospitalized black decedents would be treated more intensively in their last 12 months of life, but less intensively otherwise, and that differences in end-of-life intensity would be largely attributable to greater use of life-sustaining procedures such as mechanical ventilation, feeding tube placement, and hemodialysis.

METHODS {#Sec1}
=======

Sample Selection {#Sec2}
----------------

We initially drew a 20% sample of all decedents and a 5% sample of all survivors enrolled in Medicare in 1989, 1991, 1993, 1995, 1997, and 1999 from the Denominator file maintained by the Centers for Medicare and Medicaid Services. The data were initially assembled to study secular trends over time, so it was not felt that every year was necessary.[@CR33] For the current analyses, we removed 1985 and 1987 because these years were not comparable to the years after 1989, due to the introduction of DRGs 474 and 475 in October, 1987. After those DRGs were introduced, there was a marked jump in the coding of intubation and tracheostomy procedures, the most common inpatient intensive procedures among decedents. Regarding truncation at 1999, at the time of our initial forays into analysis (2001), 1999 was the most recent year of data available.

For each beneficiary, we assembled the acute care hospital claims from the Medicare Medical Provider Analysis and Review (MedPAR) files; for decedents, we included all claims in the 365 days preceding their death and for the survivors we included claims during the calendar year. This provided a full 12 months of enrollment and utilization experience for both survivors and decedents. We limited our analysis to patients aged 65 and older and excluded Medicare beneficiaries with discontinuous enrollment in Medicare Part A or Part B, residence outside the United States or a foreign hospital admission, enrollment in a health maintenance organization, or hospitalization in a Federal hospital during the year because these persons might have incomplete hospitalization records. For beneficiaries whose claims spanned multiple years (first as survivors and later as decedents), we randomly sampled one 12-month (survivor or decedent) claims period for the current analysis so that no beneficiary appears more than once.

We abstracted each patient's age, sex, race, and ZIP code of residence from the Social Security Administration denominator file. We classified age into 5-year increments (65--69, 70--74, 75--79, 80--84, and \>85), and analyzed race by grouping all beneficiaries into the categories "black" and "nonblack," excluding all beneficiaries with "unknown" race.[@CR34] We used ZIP code level measures of income and education from the area resource file (ARF) as proxies for these socioeconomic indicators. Individual socioeconomic status will generally be associated with area measures of income, with people living in wealthy areas having more assets and socioeconomic status than people living in poorer areas.[@CR35],[@CR36] In exploratory multivariable regressions, Charlson diagnoses provided better model fit for expenditures than Elixhauser diagnoses,[@CR37],[@CR38] so we used the presence or absence of these 18 ICD-9 clinical diagnoses for comorbidity risk adjustment.

We attributed a beneficiary's hospital care to the first hospital patronized in the 12-month sampling frame. Among survivors and decedents with at least one hospital admission in the year, over 60% and 40%, respectively, had only one claim; the remainder had two or more hospitalizations. Among all patients with at least one hospital admission, 87% of survivors and 78% of decedents in 1999 received all of their inpatient care at one hospital. We used files from the American Hospital Association (AHA) survey to identify hospitals' membership in the Council of Teaching Hospitals (COTH), financial status (for profit or not for profit, including government hospitals), and bed size. A small number of hospitals care for the vast majority of elderly black Americans.[@CR39] We constructed a variable "percent black" (percent of all admissions among blacks) to capture unmeasured hospital differences that vary systematically with black census.

Inpatient ICU and Procedure Use {#Sec3}
-------------------------------

For each beneficiary with at least one hospital admission in the 12 months, we recorded total hospital admissions, ICU admissions, and major surgical procedures. We classified a patient as having an ICU admission if the hospitalization included one or more days in a coronary care unit (CCUs) or an intensive care unit (ICUs). We condensed the International Classification of Diseases, 9th Edition (ICD-9) procedure codes into 228 categories using an algorithm nearly identical to the Clinical Classification System (CCS) developed for the Agency for Healthcare Research and Quality (AHRQ). For this study, we report data on the 88 procedure categories that are performed primarily in the inpatient setting and which were likely the primary reason for admission (see [Appendix](#App1){ref-type="app"}). We made exceptions to this rule for a handful of technologies that were newly introduced during the time period of study and that grew rapidly in use (e.g., automated implantable cardioverter defibrillator (AICD) implantation).

Statistical Analyses {#Sec4}
--------------------

We performed all computations with SAS statistical software (version 6.12, SAS Corporation, Cary, NC, USA). We categorized patients with at least one hospital admission during the year into 4 subgroups: black decedents, nonblack decedents, black survivors, and nonblack survivors, and compared their demographics, comorbidities, hospital characteristics, inpatient expenditures, and ICU and intensive procedure use. We performed multivariable logistic regression on the categorical receipt of one or more ICU admission and the receipt of one or more intensive procedures using a hierarchical model to adjust for patients clustered within hospitals. We estimated this model with the restricted maximum likelihood method, assuming unstructured covariance and treating hospital as a random effect. We performed separate regressions for decedents and survivors and included calendar year of observation in all models. Due to the marked interaction between decedent status and all outcomes, this was the most appropriate modeling strategy. To calculate the 95% confidence intervals on odds ratios from our parameter estimates and standard errors, we used the Wald first-order approximation.[@CR40]

The Institutional Review Board at Stanford University approved the study. We had complete independence from the National Institute on Aging (NIA) in the design, conduct, and reporting of the study.

RESULTS {#Sec5}
=======

Characteristics of the Study Sample {#Sec6}
-----------------------------------

The sample included 887,787 nonblack and 88,433 black decedents and 781,980 nonblack and 63,326 black survivors with at least one admission between 1989 and 1999. There were significant differences in most measured covariables between nonblacks and blacks (Table [1](#Tab1){ref-type="table"}). Table 1Characteristics of the Study Sample, by Race and Survivor Status, 1989--1999CharacteristicDecedentsSurvivorsNonblack (*N* = 887,787)Black (*N* = 88,433)*p*-valueNonblack (*N* = 781,980)Black (*N* = 63,326)*p*-valueDemographicsMean age, years80.979.9\<.000177.376.8\<.0001 Women, %54.156.3\<.000158.561.4\<.0001 College education, %17.212.8\<.000117.813.4\<.0001 Median household income, \$30,15822,535\<.000130,70623,323\<.0001Clinical comorbidities Old myocardial infarction, %6.04.4\<.00014.93.6\<.0001 Recent myocardial infarction, %13.19.9\<.00015.13.9\<.0001 Congestive heart failure, %41.838.0\<.000116.518.9\<.0001 Peripheral vascular disease, %8.811.9\<.00014.55.8\<.0001 Cerebrovascular disease, %7.011.0\<.00013.46.4\<.0001 Dementia, %9.711.4\<.00013.95.5\<.0001 Chronic obstructive pulmonary disease, %31.523.6\<.000120.116.7\<.0001 Rheumatologic disease, %2.31.8\<.00012.01.7\<.0001 Peptic ulcer disease, %0.080.05.00120.040.02.0103 Mild liver disease, %1.81.4\<.00010.60.6.0507 Moderate or severe liver disease, %1.51.2\<.00010.30.2.0204 Diabetes, %18.826.3\<.000114.323.6\<.0001 Diabetes with complications, %3.56.2\<.00011.94.0\<.0001 Hemiplegia, %6.18.3\<.00012.84.9\<.0001 Chronic renal failure, %8.413.7\<.00011.94.5\<.0001 Metastatic solid tumor, %17.818.4\<.00013.63.8.0057 Other neoplasia, %26.227.5\<.000110.410.5.374 Human immunodeficiency virus, %0.030.14\<.00010.010.06\<.0001Hospital characteristics Size, mean number of beds205252\<.0001214257\<.0001 Member of COTH\*, %12.826.1\<.000113.626.0\<.0001 For profit ownership, %10.611.9\<.000111.212.2\<.0001 Percent black, %7.029.8\<.00016.426.5\<.0001\*Council of teaching hospitals.

Intensive Care and Procedure Use {#Sec7}
--------------------------------

We present crude rates of ICU admission and the use of one or more intensive procedures by race for all years combined in Table [2](#Tab2){ref-type="table"} and by year in Figure [1](#Fig1){ref-type="fig"}. Black decedents with one or more hospitalization in the last 12 months of life were slightly more likely than nonblacks to be admitted to the ICU during the last 12 months (49.3% vs. 47.4%, *p* \< .0001) and the terminal hospitalization (41.9% vs. 40.6%, *p* \< .0001), but these differences disappeared or attenuated in multivariable hierarchical logistic regressions (last 12 months adjusted odds ratio (AOR) 1.0 \[0.99--1.03\], *p* = .36; terminal hospitalization AOR 1.03 \[1.0--1.06\], *p* = .01). Black decedents were more likely to undergo an intensive procedure during the last 12 months (49.6% vs. 42.8%, *p* \< .0001) and the terminal hospitalization (37.7% vs. 31.1%, *p* \< .0001), a difference that persisted with adjustment (last 12 months AOR 1.1 \[1.08--1.14\], *p* \< .0001; terminal hospitalization AOR 1.23 \[1.20--1.26\], *p* \< .0001). Patterns of differences in inpatient treatment intensity by race were reversed among survivors: blacks had lower rates of ICU admission (31.2% vs. 32.4%, *p* \< .0001; AOR 0.93 \[0.91--0.95\], *p* \< .0001) and intensive procedure use (36.6% vs. 44.2%; AOR 0.72 \[0.70--0.73\], *p* \< .0001). The black/nonblack difference in decedent, but not survivor, ICU and procedure use increased over time (Fig. [1](#Fig1){ref-type="fig"}). Table 2Inpatient Resource Use, by Race and Survivor Status, 1989--1999 DecedentsSurvivorsNonblack (*N* = 887,787)Black (*N* = 88,433)*p*-valueNonblack (*N* = 781,980)Black (*N* = 63,326)*p*-valueAnnual resource use One or more ICU admission, %47.449.3\<.000132.431.2\<.0001 Intensive procedure, %42.849.6\<.000144.236.6\<.0001Terminal admission resource use ICU admission, %40.641.9\<.0001------ Intensive procedure, %31.137.7\<.0001------Figure 1Trends in inpatient treatment intensity differences by race between 1989 and 1999. The gap in ICU admission (panel A) and intensive procedure use (panel B) between blacks and nonblacks has widened among decedents (dashed lines) but remained parallel or narrowed among survivors (solid lines). Overall procedure use (panel B) among nonblacks does not vary much by survivorship status; in contrast, procedure use among blacks is much higher for decedents than among survivors.

Additional predictors of inpatient treatment intensity included educational achievement in the patient's ZIP code and hospital characteristics (Table [3](#Tab3){ref-type="table"}). Notably, a 5% increase in the hospital's black census increased the odds of ICU admission 17-fold (\[14.1--20.8\], *p* \< .0001) for the last 12 months and 24-fold (\[18.6--31.0\], *p* \< .0001) for the terminal admission. This effect was much more modest among survivors (AOR 1.55 \[1.23--2.95\], *p* = .0002). A 5% increase in the hospital's black census increased the odds of an intensive procedure 8-fold (\[6.2--10.4\], *p* \< .0001) for the last 12 months and 16-fold (\[12.6--21.1\], *p* \< .0001) for the terminal admission, but decreased the odds for survivors more than 6-fold (\[0.12--0.20\], *p* \< 0.0001). Table 3Adjusted Odds\* of ICU Admission and Intensive Procedure Use, 1989--1999 Decedents Adjusted OR (95% CI)Survivors Adjusted OR (95% CI)ICU admissionIntensive procedureICU admissionIntensive procedure12-Month resource use Black race1.01 (0.99--1.03)1.11 (1.08--1.14)0.93 (0.91--0.95)0.72 (0.70--0.73) 10-Year increase in age0.604 (0.600--0.608)0.681 (0.675--0.686)0.82 (0.81--0.83)0.673 (0.668--0.679) 10% increase in college degree holders0.04 (0.02--0.07)0.11 (0.05--0.25)0.02 (0.009--0.03)1.19 (0.58--2.56) 100 bed increase in hospital size1.066 (1.062--1.070)1.127 (1.122--1.132)1.064 (1.060--1.068)1.146 (1.141--1.151) For profit hospital1.39 (1.37--1.41)1.17 (1.15--1.19)1.33 (1.31--1.35)1.11 (1.09--1.13) Teaching hospital0.86 (0.85--0.88)1.04 (1.02--1.06)0.79 (0.78--0.81)0.97 (0.95--0.99) 5% increase in black census17.14 (14.14--20.79)8.0 (6.2--10.4)1.55 (1.23--1.95)0.16 (0.12--0.20)Terminal admission resource use Black race1.03 (1.01--1.06)1.23 (1,20--1.26)---- 10-Year increase in age0.545 (0.541--0.550)0.564 (0.559--0.569)---- 10% increase in college degree holders0.17 (0.08--0.37)0.07 (0.03--0.16)---- 100 bed increase in hospital size1.066 (1.061--1.071)1.113 (1.108--1.118)---- For profit hospital1.31 (1.29--1.34)1.18 (1.16--1.20)---- Teaching hospital0.92 (0.90--0.94)1.13 (1.11--1.16)---- 5% increase in black census24.05 (18.63--31.04)16.3 (12.6--21.1)----\*Hierarchical multivariable logistic regression model adjusted for age, race, sex, ICD-9 diagnoses of old myocardial infarction (MI), recent MI, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, rheumatologic disease, peptic ulcer disease, mild liver disease, moderate--severe liver disease, diabetes, diabetes with complications, hemiplegia, chronic renal failure, neoplasia, metastatic cancer, HIV, calendar year (1989, 1991, 1993, 1995, 1997, or 1999), ZIP code measures of education (percent of persons with a college degree) and income (median income), and hospital characteristics, including membership in the Council of Teaching Hospitals (COTH), total hospital beds, hospital ownership (for profit vs. not-for-profit), and the percent of decedents who were black.

The distinct patterns of racial differences in intensive procedure use were driven by the particular procedures that predominate among decedents compared to survivors. We list each of the procedures performed among 1.5% or more of each population in Table [4](#Tab4){ref-type="table"}, indicating those that are more and less frequently performed among blacks compared to nonblacks. Specifically, such life-sustaining procedures as intubation/tracheostomy for mechanical ventilation and gastrostomy placement for enteral feeding predominated among decedents, and blacks were more likely than nonblacks to undergo these procedures, regardless of survivorship group. In contrast, cardiovascular and orthopedic procedures that have been classified by the Dartmouth Atlas of Health Care as preference- and supply-sensitive procedures, such as cardiac catheterization and revascularization and hip replacement, predominated among survivors and were less frequently performed among blacks than nonblacks. Table 4Common\* Intensive Procedure Use by Race and Survivor Status, 1989--1999ProcedureDecedentsSurvivorsNonblack (*N* = 887,787)Black (*N* = 88,433)Nonblack (*N* = 781,980)Black (*N* = 63,326)Greater use among blacksIntubation and tracheostomy, %14.519.22.02.7Feeding tube placement, %5.511.61.12.5Arteriogram or venogram (not heart or head), %2.53.12.22.8Hemodialysis, %2.25.90.62.7Revision/repair of vessel/vascular procedure, %1.32.21.12.5Creation of arteriovenous fistula, %0.72.40.31.3Lesser use among blacksCardiac catheterization, coronary arteriography, %4.63.18.45.7Treatment, fracture of hip and femur, %3.61.52.91.3Hip replacement, total and partial, %1.91.03.01.4Insert/replace/revise/remove permanent pacemaker, %1.61.41.91.5Ileostomy and colostomy, %1.61.50.60.5Coronary artery bypass graft, %1.60.73.11.2Percutaneous transluminal coronary angioplasty, %1.10.62.91.3Knee replacement, %0.30.22.81.7Open cholecystectomy, %1.21.11.71.2Laminectomy, diskectomy, arthrodesis, %0.40.31.70.9Carotid endarterectomy, %0.50.21.50.5Little difference or variable by survivorship groupTransurethral prostatectomy, %1.51.63.22.8Colon resection, %2.72.62.42.0Excision, lysis peritoneal tissue, %1.92.01.71.5\*Procedures with a prevalence of 1.5% or greater among black or nonblack decedents or survivors in the sample.

DISCUSSION {#Sec8}
==========

In this retrospective observational study using fee-for-service Medicare claims, we confirmed that black decedents were treated more intensively during hospitalization than nonblack decedents, whereas black survivors were treated less intensively. The greater use by blacks of life-sustaining treatments that predominate among decedents but lesser use of cardiovascular and orthopedic procedures that predominate among survivors explained observed racial differences in procedure use by survivorship cohort. The relatively smaller differences in end-of-life ICU use were largely at\]tributable to confounding factors, including hospital choice. Among the strongest predictors of ICU and intensive procedure use was a hospital's black census. Because the addition of black census to the hierarchical model decreased the size of the parameter estimate on black race, our study suggests that blacks' hospital choice/access in part mediates the observed relationship between treatment intensity and race.[@CR41] These systematic differences in hospital-level practice patterns may reflect local patient and community factors (e.g., preferences) or provider factors (e.g., hospital resources, staffing and organization, or process and outcomes of communication and decision making).

This is the first nationally representative study of fee-for-service Medicare beneficiaries to explore racial differences in ICU and intensive procedure use at the end of life. Most previous Medicare claims studies have focused on overall inpatient spending[@CR18],[@CR19] and none have used multilevel modeling to account for individual hospital effects. The study by Levinsky et al. that analyzed ICU and life-sustaining procedure use by age in California and Massachusetts only reported a demographic- and comorbidity-adjusted effect of black race on spending due to limited sample size of blacks.[@CR17] The multicenter Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment (SUPPORT) trial reported that black patients received less intervention than white patients among their sample of seriously ill adults that included younger patients and a mix of decedents and survivors.[@CR42]

Both end-of-life health service use and racial differences in treatment receive a great deal of policy attention. End-of-life utilization attracts interest because per person expenditures for Medicare beneficiaries who die each year are 5 times higher than for survivors.[@CR43] Indeed, between 1985 and 1999 real spending on inpatient services for fee-for-service decedents increased 60%, to \$23 billion in 1999.[@CR33] This increase in spending was neither driven by an increase in the population nor a significant increase in the age-adjusted likelihood of admission; instead, increases in per capita treatment intensity explained much of this expenditure growth. Racial differences in health service use attract interest because they may reflect differences in access or uptake that contribute to observed health disparities. Curiously, as reported by other authors, it is only at the end of life that blacks appear to have greater health services expenditures than nonblacks, particularly for inpatient services.[@CR17],[@CR19],[@CR44] In part, this is due to a higher likelihood of dying in the hospital.[@CR33] Findings from the present study additionally suggest that blacks' greater use of intensive procedures, particularly highly remunerated (pre-2006) DRGs 475 and 483 associated with intubation/tracheostomy and mechanical ventilation \>96 hours, help to explain this higher spending.

The lower rates of cardiovascular and orthopedic procedures among blacks have been previously documented, and may be due to differences in physician referral[@CR8],[@CR11],[@CR45] or to differences in patients' perceptions of outcomes and their attendant willingness to undergo surgery.[@CR46],[@CR47] Higher rates of intubation and tracheostomy and feeding tube placement are consistent with previous studies of hypothetical and real end-of-life decisions suggesting that blacks are less likely to forego life-sustaining treatments.[@CR20]--[@CR24],[@CR48] Higher rates of vascular and hemodialysis access procedures and lower rates of surgical repair of hip fracture are likely attributable to the well-documented differences in burden of vascular disease, end-stage renal disease, and osteoporosis among blacks compared to nonblacks.

The secular trends demonstrating a widening of the difference in end-of-life impatient treatment intensity between blacks and nonblacks in the latter half of the 1990s could be explained by progressively higher rates of hospice enrollment[@CR16], [@CR32] and attendant limitation of ICU admission, mechanical ventilation, and enteral feeding among nonblacks during this period. Furthermore, the minority of U.S. hospitals that care for most of America's black patients are more likely to have medical ICUs[@CR39]; other structures and processes related to treatment intensity also likely differ.

Our study is subject to several limitations. First, our study relies upon the frequently used "look back" approach to understand how dying patients are treated, though patients may not have been known to be "dying" at the time treatments were initiated.[@CR49],[@CR50] Additionally, we focused only on inpatient services and did not study trends in outpatient or postacute treatment intensity because the hospital remains the site of the most expensive and technologically intensive medical care. Our measures of utilization may have underestimated treatment intensity by calculating the receipt of one or more ICU admission or procedure over 12 months rather than the mean number of admissions and procedures. Our findings for the terminal hospitalization and for total expenditures which more closely track service volume (not reported) followed the same patterns by race and suggest that our measure of utilization does not confound the observations. Despite statistical adjustment for measured confounders, the large differences in characteristics of black and nonblack patients raise the possibility that differences are attributable to unmeasured confounders. Finally, the observations are based only upon fee-for-service Medicare and cannot be generalized to those in managed "risk plans."

Our study does not offer any information about patient preferences or the appropriateness of end-of-life treatment intensity. It does, however, raise provocative questions about differences in practice patterns at hospitals caring for black patients that deserve further study.
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Intensive procedures included in the study (in alphabetical order) {#Sec10}
==================================================================

Amputation of lower extremity

Ankle/foot joint replacement

Aortic resection with replacement

Appendectomy

Arteriogram and venogram (not heart or head)

Automated implantable cardioverter defibrillator (AICD)

Biopsy of spinal cord

Bone marrow transplant

Cardiac assist device/ECMO/bypass

Cardiac catheterization, coronary arteriography

Carotid endarterectomy

Central vessel endarterectomy/thrombectomy

Cerebral arteriogram

Cholecystectomy and common duct exploration

Closed control of UGIB

Colon resection

Coronary artery bypass graft (CABG)

Creation of arteriovenous fistula

Cycstectomy

Electrophysiology study (EPS) +/- ablation

Enterostomy

Esophageal dilation

Esophageal reanastamosis/repair

Esophagectomy

Excision, lysis peritoneal tissue

Exploratory laparotomy

Feeding tube placement

Fundoplication

Genitourinary incontinence procedures

Hemodialysis

Hip replacement, total and partial

Hysterectomy

Ileostomy and colostomy

Injection or ligation of esophageal varices

Insert/repl/revise/remove permananent pacemaker

Insertion, temporary cardiac pacemaker

Intracoronary artery thrombolytic infusion

Intubation and Tracheostomy

Jaw fracture repair

Kidney transplant

Knee replacement

Laminectomy, diskectomy, arthrodesis

Laparoscopic cholecystectomy

Laryngectomy

Lobectomy

Local excision lung/bronchus

Mastectomy

Mastoidectomy

Mediastinoscopy

Nephrectomy

Oophorectomy, unilateral and bilateral

Open biopsy lung/bronchus

Open cholecystectomy

Open CNS biopsy

Open CNS diagnostic procedures

Open CNS therapeutic procedures

Open control of UGIB

Open heart repair of septal defects, etc.

Open or closed cardiac massage

Open Prostatectomy

Orchiectomy

Pancreatectomy/pancreaticoduodenectomy

Partial/total gastrectomy and gastric bypass

Pelvic exenteration

Percutaneous CNS biopsy (stereotactic/burr hole)

Percutaneous transluminal coronary angioplasty (PTCA)

Pericardial procedure

Peripheral vascular bypass

Peripheral vessel endarterectomy/thrombectomy

Pneumonectomy

Pyloroplasty

Radical Prostatectomy

Regional/radical lymph-node dissection

Revision/repair of vessel/vascular Procedure

Skin graft

Small bowel resection

Splenectomy

Surgical removal of urinary calculus

Thoracotomy

Thyroidectomy

Transurethral Prostatectomy (TURP)

Treatment, fracture of hip and femur

Treatment, fracture of lower extremity

Treatment, fracture of radius and ulna

Vagotomy

Valve procedures (including replacement)

Vena cava interruption

Ventricular shunt
